{
  "pmcid": "8820776",
  "sha256": "ebad5e7062f7dbc2e7df0f1dca0c2588d71d42e00508562ae230d182cc5fd7a6",
  "timestamp_utc": "2025-11-09T22:59:38.323155+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 16.255744574706913,
    "reading_ease": -1.7031928161636074,
    "word_count": 211
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Physical Activity Intervention in Colorectal Cancer Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants aged ≥20 years scheduled for elective colorectal cancer surgery were eligible."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention included aerobic activity and inspiratory muscle training 2 weeks preoperatively and 4 weeks postoperatively."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the effect of a short-term, unsupervised exercise intervention on self-assessed physical recovery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was self-assessed physical recovery 4 weeks postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "761 participants were randomised (intervention: 379, control: 382)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "668 participants (intervention: 317, control: 351) were analysed using intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention showed no effect on the primary outcome (adjusted odds ratio 0.84, 95% CI 0.62–1.15)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov NCT02299596."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}